why choose us

First received: January 30, 2023

Clinical Trial: Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse

Study Status: Completed

Recruit Status: Completed

Condition: Inflammatory Bowel Diseases
Rheumatic Disorder

Study Type: Observational


Official Title: Impact of Adalimumab Withdrawal or Continuation on Severity of COVID-19 and Risk of IMID Relapse

Brief Summary: This study is a retrospective pharmacological study, of a historical cohort. Collection of Retrospective data from February 2020 to 30 September 2021 The index date is the date of COVID-19 positive PCR test. The data will be collected until last news (last clinical visit or death).There are no defined study visits. In the course of the study, the clinical data recorded are those corresponding to the standard medical procedure.The goal of this study is to assess the impact on continuing or stopping adalimumab…

Read more